SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for APPLIED GENETIC TECHNOLOGIES CORP (CIK 0001273636) — Feb 4, 2020

APPLIED GENETIC TECHNOLOGIES CORP (CIK 0001273636)
Date: Feb. 4, 2020 · CIK: 0001273636 · Accession: 0000000000-20-001069

AI Filing Summary & Sentiment

File numbers found in text: 333-236156

Date
February 4, 2020
Author
Not clearly detected
Form
UPLOAD
Company
APPLIED GENETIC TECHNOLOGIES CORP (CIK 0001273636)

Letter

February 4, 2020 Susan B. Washer Chief Executive Officer Applied Genetic Technologies Corporation 14193 NW 119th Terrace, Suite 10 Alachua, FL 32615 Re:Applied Genetic Technologies Corporation Registration Statement on Form S-1 Filed January 29, 2020 File No. 333-236156 Dear Ms. Washer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stacie S. Aarestad, Esq.

Show Raw Text
February 4, 2020
Susan B. Washer
Chief Executive Officer
Applied Genetic Technologies Corporation
14193 NW 119th Terrace, Suite 10
Alachua, FL 32615
Re:Applied Genetic Technologies Corporation
Registration Statement on Form S-1
Filed January 29, 2020
File No. 333-236156
Dear Ms. Washer:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Stacie S. Aarestad, Esq.